about
Current status and perspectives of targeted therapy in well-differentiated neuroendocrine tumorsAdvanced MR imaging of gliomas: an updateVascular pathology in multiple sclerosis: mind boosting or myth busting?Targeted therapies for gastric cancer: current status.A pharmacokinetic binding model for bevacizumab and VEGF165 in colorectal cancer patientsNovel therapies in glioblastoma.Chemical and Radiation-Associated Jaw Lesions.The role of vascular endothelial growth factor in the pathogenesis, diagnosis and treatment of malignant pleural effusionRamucirumab for the treatment of gastroesophageal cancers.A peptide derived from TIMP-3 inhibits multiple angiogenic growth factor receptors and tumour growth and inflammatory arthritis in mice.Assessing causal relationships between treatments and clinical outcomes: always read the fine print.Trials of bevacizumab in breast cancer--a safety review.Antiangiogenic therapy for patients with recurrent and newly diagnosed malignant gliomas.Bevacizumab-induced oral mucositis in background of cutaneous plaque-type psoriasis.Bevacizumab-induced hypertension: Clinical presentation and molecular understanding.
P2860
Q26823873-4169C9FB-9877-46D6-863D-D200F1A37D73Q30655700-7AF01CD7-E31E-4CE4-BFA8-A312F2183816Q33960741-671AB65B-984B-45FC-8B00-C54C158C318BQ34205672-E52D673D-9F88-4C14-97E3-E368232E9109Q35193385-C65CF24B-4850-467B-ABEB-E0E59A982C49Q35864136-A3ED45FE-2A87-407C-9ED2-02DD2520A02EQ36604330-6AF9158A-ADFB-4BE9-B16F-CC78BC341085Q36907325-722C82C4-4440-4384-A335-22E9FE35254CQ37211153-2E00F6A9-F535-408A-A1FE-8E714EC84A21Q37502925-2CD345D9-26EC-47EE-B186-4222E0AC3591Q37882393-89F26516-70C1-4A67-82A1-E33AF56FBC0CQ37887823-63FA22FA-3F9F-439B-864E-A137404CD73BQ42143173-46942D05-2F12-4A85-A8BA-D2476D056A68Q48312769-F9E5E32A-7E97-424D-84D0-EBD12B46AC3DQ50204127-910DDFB4-E20F-4A51-A6B2-12969FB1FA8A
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Bevacizumab.
@ast
Bevacizumab.
@en
type
label
Bevacizumab.
@ast
Bevacizumab.
@en
prefLabel
Bevacizumab.
@ast
Bevacizumab.
@en
P2093
P2860
P1433
P1476
Bevacizumab.
@en
P2093
Filis Kazazi-Hyseni
Jan H M Schellens
Jos H Beijnen
P2860
P304
P356
10.1634/THEONCOLOGIST.2009-0317
P577
2010-08-05T00:00:00Z